The share of public procurement in the overall structure of drug sales in Russian pharmaceutical market has reached 34.4% in the first half of 2019, which became a historical record figure for the cou...
The Federal Antimonopoly Service of the Russian Federation opened the case based on the monitoring of public drug and medical products procurement.
'Axonmed' Ltd., 'Device' Ltd., 'InterMed' Ltd., '...
Nacimbio concluded eight new contracts with the Ministry of Health of the Russian Federation for the supply of four units (INN) of blood plasma products.
In 2018, the number of pharma companies supporting further restriction or ban on participation of foreign producers in public procurement, increased to 63%.
In 2018, 914.6 billion sums will be allocated to ensure the procurement of medicinal products and medical devices for state medical institutions in Uzbekistan, which is 2.5 times more than in 2017.
The Minister of Health of Kazakhstan spoke about the issues related to provision of medicines to the people of Kazakhstan, including public procurement of medicinal products by the single distributor.
A number of new innovative drugs were added to the list of free medicines including those for the treatment of tuberculosis. This was announced by the Kazakhstan’s Minister of Health Elzhan Birtanov at a public meeting.
A relevant draft order on additional preferences for manufacturers is being prepared for state registration in the Ministry of Justice, announced the press service of the Russian Ministry of Industry and Trade.
Pharmstandard turned out to be the only pharmaceutical company that made a bid for supplying rilpivirine + tenofovir + emtricitabine, a three-component antiretroviral medication included in the list of vital and essential drugs.
Russian Prime Minister Dmitry Medvedev signed the Decree No. 572 of May 12, 2018, aimed at supporting the manufacturers of medicinal products that perform all stages of production.
The mechanisms that will allow to regulate the prices of medicinal products in wholesale and retail trade will be introduced in accordance with the order of the President of Kazakhstan.
Nacimbio JSC, a pharmaceutical subsidiary of Rostec Corporation, signed four new contracts with the Russian Ministry of Health for 2018 supplies of blood-derived products under the Seven Nosologies program.
The Ministry of Health of the Russian Federation announced the results of the tender for supply of dasabuvir/ombitasvir/paritaprevir/ritonavir, a new drug for hepatitis C. As it was expected, the declared winner was R-Pharm.
According to IQVIA, in 2017, the Russian market of anti-tumor drugs was about 72 billion rubles in value terms and amounted to 14 million packages in physical terms.
Since the start of 2018, GlaxoSmithKline Trading CJSC, the Russian division of British GSK, has won five competitive bids to supply the drugs against HIV, hepatitis B, C and tuberculosis.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK